<div id="readability-page-1"><p><span>RenaissanceRe (NYSE:RNR - Get Free Report)</span> had its target price hoisted by analysts at Keefe, Bruyette &amp; Woods  from $314.00 to $323.00 in a research report issued on Monday,Benzinga reports. The firm currently has a &#34;market perform&#34; rating on the insurance provider's stock. Keefe, Bruyette &amp; Woods' target price would indicate a potential upside of 9.03% from the company's previous close.</p><div><p><span></span><span>Get <strong>RenaissanceRe</strong> alerts:</span></p></div><p>Several other research firms also recently commented on RNR. Evercore boosted their price target on shares of RenaissanceRe from $283.00 to $291.00 and gave the stock an &#34;in-line&#34; rating in a research note on Wednesday, February 4th. TD Cowen  reiterated a &#34;hold&#34; rating on shares of RenaissanceRe in a report on Thursday, January 8th. Barclays upped their price target on RenaissanceRe from $278.00 to $304.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, January 8th. The Goldman Sachs Group  reiterated a &#34;sell&#34; rating and issued a $267.00 price objective on shares of RenaissanceRe in a research note on Wednesday, January 7th. Finally, Weiss Ratings  restated a &#34;buy (b)&#34; rating on shares of RenaissanceRe in a research note on Monday, December 29th. Four investment analysts have rated the stock with a Buy rating, fourteen have assigned  a Hold rating and one  has given a Sell rating to the stock. According to data from MarketBeat, RenaissanceRe presently has an average rating of &#34;Hold&#34; and a consensus target price of $306.60.</p><p><b>Check Out Our Latest Report on RenaissanceRe</b></p><h2>RenaissanceRe Trading Down 1.4%</h2><p>RNR traded down $4.32 during mid-day trading on Monday, hitting $296.24. 18,455 shares of the stock were exchanged, compared to its average volume of 385,315. The firm's fifty day moving average is $276.11 and its two-hundred day moving average is $259.36. RenaissanceRe has a 1-year low of $219.00 and a 1-year high of $310.80. The company has a market cap of $13.66 billion, a PE ratio of 5.24, a PEG ratio of 0.74 and a beta of 0.24. The company has a current ratio of 1.43, a quick ratio of 1.40 and a debt-to-equity ratio of 0.21. </p><p>RenaissanceRe (NYSE:RNR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.59 by $2.75. The business had revenue of $2.97 billion for the quarter, compared to analysts' expectations of $1.73 billion. RenaissanceRe had a net margin of 20.88% and a return on equity of 18.29%. The business's quarterly revenue was up 29.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $8.06 earnings per share.  Equities analysts forecast that  RenaissanceRe will post 26.04 earnings per share for the current fiscal year. </p><h2>Insiders Place Their Bets</h2><p>In other news, EVP Robert Qutub sold 5,000 shares of the business's stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $305.75, for a total transaction of $1,528,750.00. Following the completion of the sale, the executive vice president owned 73,023 shares in the company, valued at approximately $22,326,782.25. The trade was a 6.41% decrease in their position. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this link. Insiders own  1.30% of the company's stock. </p><h2>Institutional Investors Weigh In On RenaissanceRe</h2><p>A number of institutional investors and hedge funds have recently bought and sold shares of RNR. Hantz Financial Services Inc. lifted its holdings in shares of  RenaissanceRe by 707.1% in the 2nd quarter. Hantz Financial Services Inc. now owns 113 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 99 shares during the last quarter.  IFP Advisors Inc increased its position in  RenaissanceRe by 160.0% during the second quarter. IFP Advisors Inc now owns 117 shares of the insurance provider's stock worth $28,000 after buying an additional 72 shares during the period.  Financial Consulate Inc. purchased a new stake in  RenaissanceRe in the third quarter valued at approximately $29,000.  Huntington National Bank boosted its holdings in shares of  RenaissanceRe by 80.9% in the second quarter. Huntington National Bank now owns 123 shares of the insurance provider's stock valued at $30,000 after acquiring an additional 55 shares during the period.  Finally, Farther Finance Advisors LLC grew its position in shares of  RenaissanceRe by 151.9% during the third quarter. Farther Finance Advisors LLC now owns 131 shares of the insurance provider's stock worth $33,000 after acquiring an additional 79 shares during the last quarter. 99.97% of the stock is owned by hedge funds and other institutional investors. </p><h2>About RenaissanceRe</h2> (Get Free Report)<p>RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.  </p><p>The company operates through two primary segments: Reinsurance and Insurance.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than RenaissanceRe</li><li>Buy this Gold Stock Before May 2026</li><li>Your Bank Account Is No Longer Safe</li><li>The day the gold market broke</li><li>What a Former CIA Agent Knows About the Coming Collapse</li><li>He just nailed another gold prediction …</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJOUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJOUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in RenaissanceRe Right Now?</h2><p>Before you consider RenaissanceRe, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RenaissanceRe wasn't on the list.</p><p>While RenaissanceRe currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Keefe, Bruyette & Woods raised the price target for RenaissanceRe (NYSE:RNR) from $314.00 to $323.00, maintaining a "market perform" rating. This new target suggests a potential upside of 9.03% from the previous close. Other firms have also adjusted their ratings, with an average consensus target price of $306.60. RenaissanceRe's stock recently traded down 1.4% to $296.24, with a market cap of $13.66 billion and a PE ratio of 5.24. The company reported strong quarterly earnings, exceeding estimates with $13.34 EPS and $2.97 billion in revenue.</p>

RenaissanceRe (NYSE:RNR) Price Target Raised to $323.00 at Keefe, Bruyette & Woods